Cardiotoxicity of nano-particles

Life Sciences

Volumn 165, Issue , 2016, Pages 91-99

  Bostan, Hasan Badie ^a   Rezaee, Ramin ^b,d   Valokala, Mahmoud Gorji ^a   Tsarouhas, Konstantinos ^c   Golokhvast, Kirill ^d   Tsatsakis, Aristidis M ^e   Karimi, Gholamreza ^a  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NORTH KHORASAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

^d FAR EASTERN FEDERAL UNIVERSITY   (Russian Federation)

^e UNIVERSITY OF CRETE   (Greece)

Author keywords

Cardiac toxicity; Inflammatory marker; Nano particle; Reactive oxygen species

Indexed keywords

CARBON NANOPARTICLE; SILICA NANOPARTICLE; SILVER NANOPARTICLE; TITANIUM DIOXIDE NANOPARTICLE; ULTRASMALL SUPERPARAMAGNETIC IRON OXIDE; ZINC OXIDE NANOPARTICLE; NANOPARTICLE;

BIOCOMPATIBILITY; CARDIOTOXICITY; CARDIOVASCULAR EFFECT; HEART FUNCTION; HUMAN; NANOTOXICOLOGY; NONHUMAN; OXIDATIVE STRESS; PHYSICAL CHEMISTRY; REVIEW; DRUG EFFECTS; HEART;

HEART; HUMANS; NANOPARTICLES;

EID: 84989204337     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2016.09.017     Document Type: Review

References (108)

1. [1] Karmakar, A., Zhang, Q., Zhang, Y., Neurotoxicity of nanoscale materials. J. Food Drug Anal. 22:1 (2014), 147–160.
2. [2] Medina, C., et al. Nanoparticles: pharmacological and toxicological significance. Br. J. Pharmacol. 150:5 (2007), 552–558.
3. [3] Perin, E.C., Lopez, J., Methods of stem cell delivery in cardiac diseases. Nat. Clin. Pract. Cardiovasc. Med. 3:Suppl 1 (2006), S110–S113.
4. [4] Somasuntharam, I., et al. Delivery of Nox2-NADPH oxidase siRNA with polyketal nanoparticles for improving cardiac function following myocardial infarction. Biomaterials 34:31 (2013), 7790–7798.
5. [5] Ghanbari, H., de Mel, A., Seifalian, A.M., Cardiovascular application of polyhedral oligomeric silsesquioxane nanomaterials: a glimpse into prospective horizons. Int. J. Nanomedicine 6 (2011), 775–786.
6. [6] Manke, A., Wang, L., Rojanasakul, Y., Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed. Res. Int., 2013, 2013, 942916.
7. [7] Guo, C., et al. Silica nanoparticles induce oxidative stress, inflammation, and endothelial dysfunction in vitro via activation of the MAPK/Nrf2 pathway and nuclear factor-kappaB signaling. Int. J. Nanomedicine 10 (2015), 1463–1477.
8. [8] Zhou, T., Chuang, C.C., Zuo, L., Molecular characterization of reactive oxygen species in myocardial ischemia-reperfusion injury. Biomed. Res. Int., 2015, 2015, 864946.
9. [9] Chen, R. et al., Subchronic toxicity and cardiovascular responses in spontaneously hypertensive rats after exposure to multiwalled carbon nanotubes by intratracheal instillation. Chem. Res. Toxicol. 28:3 (2015), 440–450.
10. [10] Sheng, L., et al. Cardiac oxidative damage in mice following exposure to nanoparticulate titanium dioxide. J. Biomed. Mater. Res. A 101:11 (2013), 3238–3246.
11. [11] Nel, A., et al. Toxic potential of materials at the nanolevel. Science 311:5761 (2006), 622–627.
12. [12] Chen, J., et al. Effects of titanium dioxide nano-particles on growth and some histological parameters of zebrafish (Danio rerio) after a long-term exposure. Aquat. Toxicol. 101:3–4 (2011), 493–499.
13. [13] Duan, Y., et al. The effects of nano-anatase TiO(2) on the activation of lactate dehydrogenase from rat heart. Biol. Trace Elem. Res. 130:2 (2009), 162–171.
14. [14] Bu, Q., et al. NMR-based metabonomic study of the sub-acute toxicity of titanium dioxide nanoparticles in rats after oral administration. Nanotechnology, 21(12), 2010, 125105.
15. [15] Faddah, L.M., et al. Biochemical responses of nanosize titanium dioxide in the heart of rats following administration of idepenone and quercetin. Afr. J. Pharm. Pharmacol 7:38 (2013), 2639–2651.
16. [16] Chandra, R.K., Excessive intake of zinc impairs immune responses. JAMA 252:11 (1984), 1443–1446.
17. [17] Colvin, V.L., The potential environmental impact of engineered nanomaterials. Nat. Biotechnol. 21:10 (2003), 1166–1170.
18. [18] Sharma, V., et al. Induction of oxidative stress, DNA damage and apoptosis in mouse liver after sub-acute oral exposure to zinc oxide nanoparticles. Mutat. Res. 745:1–2 (2012), 84–91.
19. [19] Hillyer, J.F., Albrecht, R.M., Gastrointestinal persorption and tissue distribution of differently sized colloidal gold nanoparticles. J. Pharm. Sci. 90:12 (2001), 1927–1936.
20. [20] Vandebriel, R.J., De Jong, W.H., A review of mammalian toxicity of ZnO nanoparticles. Nanotechnol. Sci. Appl. 5 (2012), 61–71.
21. [21] Guo, D., et al. Reactive oxygen species-induced cytotoxic effects of zinc oxide nanoparticles in rat retinal ganglion cells. Toxicol. in Vitro 27:2 (2013), 731–738.
22. [22] Pasupuleti, S., et al. Toxicity of zinc oxide nanoparticles through oral route. Toxicol. Ind. Health 28:8 (2012), 675–686.
23. [23] Chuang, H.C., et al. Cardiopulmonary toxicity of pulmonary exposure to occupationally relevant zinc oxide nanoparticles. Nanotoxicology 8:6 (2014), 593–604.
24. [24] Baky, N.A., et al. Induction of inflammation, DNA damage and apoptosis in rat heart after oral exposure to zinc oxide nanoparticles and the cardioprotective role of alpha-lipoic acid and vitamin E. Drug Res. 63:5 (2013), 228–236.
25. [25] Suematsu, N., et al. Oxidative stress mediates tumor necrosis factor-alpha-induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 107:10 (2003), 1418–1423.
26. [26] de Ferranti, S.D., Rifai, N., C-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc. Pathol. 16:1 (2007), 14–21.
27. [27] Hasenfuss, G., Alterations of calcium-regulatory proteins in heart failure. Cardiovasc. Res. 37:2 (1998), 279–289.
28. [28] Huang, T.H., Lee, H., Kao, C.T., Evaluation of the genotoxicity of zinc oxide eugenol-based, calcium hydroxide-based, and epoxy resin-based root canal sealers by comet assay. J. Endocrinol. 27:12 (2001), 744–748.
29. [29] Sharma, V., et al. DNA damaging potential of zinc oxide nanoparticles in human epidermal cells. Toxicol. Lett. 185:3 (2009), 211–218.
30. [30] Martinez, G.R., et al. Oxidative and alkylating damage in DNA. Mutat. Res. 544:2–3 (2003), 115–127.
31. [31] Taju, G., et al. In vitro assay for the toxicity of silver nanoparticles using heart and gill cell lines of Catla catla and gill cell line of Labeo rohita. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 161 (2014), 41–52.
32. [32] Kim, Y.S., et al. Subchronic oral toxicity of silver nanoparticles. Part. Fibre Toxicol., 7, 2010, 20.
33. [33] Hadrup, N., Lam, H.R., Oral toxicity of silver ions, silver nanoparticles and colloidal silver – a review. Regul. Toxicol. Pharmacol. 68:1 (2014), 1–7.
34. [34] Carlson, C., et al. Unique cellular interaction of silver nanoparticles: size-dependent generation of reactive oxygen species. J. Phys. Chem. B 112:43 (2008), 13608–13619.
35. [35] AshaRani, P.V., et al. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS Nano 3:2 (2009), 279–290.
36. [36] Hussain, S.M., et al. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicol. Sci. 92:2 (2006), 456–463.
37. [37] Ebabe Elle, R., et al. Dietary exposure to silver nanoparticles in Sprague-Dawley rats: effects on oxidative stress and inflammation. Food Chem. Toxicol. 60 (2013), 297–301.
38. [38] Korani, M., Rezayat, S.M., Arbabi Bidgoli, S., Sub-chronic dermal toxicity of silver nanoparticles in guinea pig: special emphasis to heart, bone and kidney toxicities. Iran J. Pharm. Res. 12:3 (2013), 511–519.
39. [39] Joseph-Silverstein, J., et al. Basic fibroblast growth factor in the chick embryo: immunolocalization to striated muscle cells and their precursors. J. Cell Biol. 108:6 (1989), 2459–2466.
40. [40] Liao, S., et al. Biological functions of the low and high molecular weight protein isoforms of fibroblast growth factor-2 in cardiovascular development and disease. Dev. Dyn. 238:2 (2009), 249–264.
41. [41] Tomanek, R.J., et al. VEGF and bFGF stimulate myocardial vascularization in embryonic chick. Am. J. Phys., 274(5 Pt 2), 1998 (pp. H1620-6).
42. [42] Zheng, W., et al. Bradycardia-induced coronary angiogenesis is dependent on vascular endothelial growth factor. Circ. Res. 85:2 (1999), 192–198.
43. [43] Shvedova, A.A., et al. ESR evidence for in vivo formation of free radicals in tissue of mice exposed to single-walled carbon nanotubes. Free Radic. Biol. Med. 73 (2014), 154–165.
44. [44] Ge, C., et al. Acute pulmonary and moderate cardiovascular responses of spontaneously hypertensive rats after exposure to single-wall carbon nanotubes. Nanotoxicology 6:5 (2012), 526–542.
45. [45] Shvedova, A.A., et al. Antioxidant balance and free radical generation in vitamin e-deficient mice after dermal exposure to cumene hydroperoxide. Chem. Res. Toxicol. 15:11 (2002), 1451–1459.
46. [46] Shvedova, A.A., et al. Mechanisms of carbon nanotube-induced toxicity: focus on oxidative stress. Toxicol. Appl. Pharmacol. 261:2 (2012), 121–133.
47. [47] Lam, C.W., et al. A review of carbon nanotube toxicity and assessment of potential occupational and environmental health risks. Crit. Rev. Toxicol. 36:3 (2006), 189–217.
48. [48] Akbar, S., Taimoor, A.A., Functionalization of carbon nanotubes: manufacturing techniques and properties of customized nanocomponents for molecular-level technology. Recent Pat. Nanotechnol. 3:2 (2009), 154–161.
49. [49] Kreyling, W.G., et al. Size dependence of the translocation of inhaled iridium and carbon nanoparticle aggregates from the lung of rats to the blood and secondary target organs. Inhal. Toxicol. 21:Suppl 1 (2009), 55–60.
50. [50] Reddy, A.R., et al. Evaluation of oxidative stress and anti-oxidant status in rat serum following exposure of carbon nanotubes. Regul. Toxicol. Pharmacol. 59:2 (2011), 251–257.
51. [51] Matthews, I.P., et al. Maximal extent of translocation of single-walled carbon nanotubes from lung airways of the rat. Environ. Toxicol. Pharmacol. 35:3 (2013), 461–464.
52. [52] Urankar, R.N., et al. Expansion of cardiac ischemia/reperfusion injury after instillation of three forms of multi-walled carbon nanotubes. Part Fibre Toxicol, 9, 2012, 38.
53. [53] Vistnes, M., et al. Circulating cytokine levels in mice with heart failure are etiology dependent. J. Appl. Physiol. 108:5 (2010), 1357–1364.
54. [54] Bonaros, N., et al. CCR3- and CXCR4-mediated interactions regulate migration of CD34 + human bone marrow progenitors to ischemic myocardium and subsequent tissue repair. J. Thorac. Cardiovasc. Surg. 136:4 (2008), 1044–1053.
55. [55] Falcone, C., et al. Markers of eosinophilic inflammation and risk prediction in patients with coronary artery disease. Eur. J. Clin. Investig. 36:4 (2006), 211–217.
56. [56] Stapleton, P.A., et al. Impairment of coronary arteriolar endothelium-dependent dilation after multi-walled carbon nanotube inhalation: a time-course study. Int. J. Mol. Sci. 13:11 (2012), 13781–13803.
57. [57] Wierzbicki, M., et al. Carbon nanoparticles downregulate expression of basic fibroblast growth factor in the heart during embryogenesis. Int. J. Nanomedicine 8 (2013), 3427–3435.
58. [58] Murugesan, S., et al. Carbon inhibits vascular endothelial growth factor- and fibroblast growth factor-promoted angiogenesis. FEBS Lett. 581:6 (2007), 1157–1160.
59. [59] Thompson, L.C., et al. C(6)(0) exposure augments cardiac ischemia/reperfusion injury and coronary artery contraction in Sprague-Dawley rats. Toxicol. Sci. 138:2 (2014), 365–378.
60. [60] Thompson, L.C., et al. Pulmonary instillation of multi-walled carbon nanotubes promotes coronary vasoconstriction and exacerbates injury in isolated hearts. Nanotoxicology 8:1 (2014), 38–49.
61. [61] Martin, K.R., The chemistry of silica and its potential health benefits. J. Nutr. Health Aging 11:2 (2007), 94–97.
62. [62] Duan, J., et al. Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. Biomaterials 34:23 (2013), 5853–5862.
63. [63] Chen, Z., et al. Age-related differences in pulmonary and cardiovascular responses to SiO2 nanoparticle inhalation: nanotoxicity has susceptible population. Environ. Sci. Technol. 42:23 (2008), 8985–8992.
64. [64] Du, Z., et al. Cardiovascular toxicity of different sizes amorphous silica nanoparticles in rats after intratracheal instillation. Cardiovasc. Toxicol. 13:3 (2013), 194–207.
65. [65] Gauderman, W.J., et al. The effect of air pollution on lung development from 10 to 18 years of age. N. Engl. J. Med. 351:11 (2004), 1057–1067.
66. [66] Galagudza, M., et al. Passive targeting of ischemic-reperfused myocardium with adenosine-loaded silica nanoparticles. Int. J. Nanomedicine 7 (2012), 1671–1678.
67. [67] Hamilton, J.M., et al. Visuospatial deficits predict rate of cognitive decline in autopsy-verified dementia with Lewy bodies. Neuropsychology 22:6 (2008), 729–737.
68. [68] Lin, Q., et al. Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276:5317 (1997), 1404–1407.
69. [69] Illi, B., et al. Epigenetic histone modification and cardiovascular lineage programming in mouse embryonic stem cells exposed to laminar shear stress. Circ. Res. 96:5 (2005), 501–508.
70. [70] Pierpont, M.E., Markwald, R.R., Lin, A.E., Genetic aspects of atrioventricular septal defects. Am. J. Med. Genet. 97:4 (2000), 289–296.
71. [71] Liu, S.Y., et al. Toxicology studies of a superparamagnetic iron oxide nanoparticle in vivo. Adv. Mater. Res. 47-50 (2008), 1097–1100.
72. [72] Mahmoudi, M., et al. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem. Rev. 112:4 (2012), 2323–2338.
73. [73] Sun, J., et al. Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells: cytotoxicity, permeability, and inflammation of metal oxide nanoparticles. Cell Biol. Toxicol. 27:5 (2011), 333–342.
74. [74] Hong, S.C., et al. Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups. Int. J. Nanomedicine 6 (2011), 3219–3231.
75. [75] Iversen, N.K., et al. Superparamagnetic iron oxide polyacrylic acid coated gamma-Fe2O3 nanoparticles do not affect kidney function but cause acute effect on the cardiovascular function in healthy mice. Toxicol. Appl. Pharmacol. 266:2 (2013), 276–288.
76. [76] Xu, J., et al. Acute toxicity of intravenously administered titanium dioxide nanoparticles in mice. PLoS One, 8(8), 2013, e70618.
77. [77] Faddah, L., et al. Biochemical responses of nanosize titanium dioxide in the heart of rats following administration of idepenone and quercetin LM Faddah*, Nayira A. Abdel Baky, Nouf M. Al-Rasheed and Nawal M. Al-Rasheed. Afr. J. Pharm. Pharmacol 7:38 (2013), 2639–2651.
78. [78] Liu, H., et al. Biochemical toxicity of nano-anatase TiO2 particles in mice. Biol. Trace Elem. Res. 129:1–3 (2009), 170–180.
79. [79] Sheng, L., et al. Cardiac oxidative damage in mice following exposure to nanoparticulate titanium dioxide. J. Biomed. Mater. Res. A 101:11 (2013), 3238–3246.
80. [80] Chen, J., et al. Effects of titanium dioxide nano-particles on growth and some histological parameters of zebrafish (Danio rerio) after a long-term exposure. Aquat. Toxicol. 101:3 (2011), 493–499.
81. [81] Duan, Y., et al. The effects of nano-anatase TiO2 on the activation of lactate dehydrogenase from rat heart. Biol. Trace Elem. Res. 130:2 (2009), 162–171.
82. [82] Savi, M., et al. Titanium dioxide nanoparticles promote arrhythmias via a direct interaction with rat cardiac tissue. Part Fibre Toxicol, 11, 2014, 63.
83. [83] Wang, B., et al. Acute toxicity of nano-and micro-scale zinc powder in healthy adult mice. Toxicol. Lett. 161:2 (2006), 115–123.
84. [84] Chuang, H.-C., et al. Cardiopulmonary toxicity of pulmonary exposure to occupationally relevant zinc oxide nanoparticles. Nanotoxicology 8:6 (2014), 593–604.
85. [85] Bessemer, R.A., et al. Cardiorespiratory toxicity of environmentally relevant zinc oxide nanoparticles in the freshwater fish Catostomus commersonii. Nanotoxicology 9:7 (2015), 861–870.
86. [86] Baky, N., et al. Induction of inflammation, DNA damage and apoptosis in rat heart after oral exposure to zinc oxide nanoparticles and the cardioprotective role of α-lipoic acid and vitamin E. Drug Res. 63:05 (2013), 228–236.
87. [87] Rathore, M., et al. Comparative in vivo assessment of the subacute toxicity of gold and silver nanoparticles. J. Nanopart. Res. 16:4 (2014), 1–12.
88. [88] Elle, R.E., et al. Dietary exposure to silver nanoparticles in Sprague–Dawley rats: effects on oxidative stress and inflammation. Food Chem. Toxicol. 60 (2013), 297–301.
89. [89] Taju, G., et al. In vitro assay for the toxicity of silver nanoparticles using heart and gill cell lines of Catla catla and gill cell line of Labeo rohita. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 161 (2014), 41–52.
90. [90] Holland, N.A., Intratracheal Instillation of Silver Nanoparticles Exacerbates Cardiac Ischemia/reperfusion Injury in Male Sprague-Dawley Rats. 2014.
91. [91] Roberts, J.R., et al. Pulmonary and cardiovascular responses of rats to inhalation of silver nanoparticles. J. Toxic. Environ. Health A 76:11 (2013), 651–668.
92. [92] Hotowy, A., et al. Silver nanoparticles administered to chicken affect VEGFA and FGF2 gene expression in breast muscle and heart. Nanoscale Res. Lett. 7:1 (2012), 1–8.
93. [93] Cho, J.-G., et al. Stepwise embryonic toxicity of silver nanoparticles on Oryzias latipes. Biomed. Res. Int., 2013, 2013.
94. [94] Paula, M.M.d.S., et al. In vitro effect of silver nanoparticles on creatine kinase activity. J. Braz. Chem. Soc. 20 (2009), 1556–1560.
95. [95] Duan, J., et al. Low-dose exposure of silica nanoparticles induces cardiac dysfunction via neutrophil-mediated inflammation and cardiac contraction in zebrafish embryos. Nanotoxicology 10:5 (2016), 575–585.
96. [96] Ge, C., et al. Acute pulmonary and moderate cardiovascular responses of spontaneously hypertensive rats after exposure to single-wall carbon nanotubes. Nanotoxicology 6:5 (2012), 526–542.
97. [97] Shvedova, A., et al. ESR evidence for in vivo formation of free radicals in tissue of mice exposed to single-walled carbon nanotubes. Free Radic. Biol. Med. 73 (2014), 154–165.
98. [98] Urankar, R.N., et al. Expansion of cardiac ischemia/reperfusion injury after instillation of three forms of multi-walled carbon nanotubes. Part. Fibre Toxicol., 9(1), 2012, 1.
99. [99] Chen, Z., et al. Age-related differences in pulmonary and cardiovascular responses to SiO2 nanoparticle inhalation: nanotoxicity has susceptible population. Environ. Sci. Technol. 42:23 (2008), 8985–8992.
100. [100] Aburawi, E.H., et al. Biocompatibility of calcined Mesoporous silica particles with ventricular myocyte structure and function. Chem. Res. Toxicol. 26:1 (2012), 26–36.
101. [101] Duan, J., et al. Cardiovascular toxicity evaluation of silica nanoparticles in endothelial cells and zebrafish model. Biomaterials 34:23 (2013), 5853–5862.
102. [102] Du, Z., et al. Cardiovascular toxicity of different sizes amorphous silica nanoparticles in rats after intratracheal instillation. Cardiovasc. Toxicol. 13:3 (2013), 194–207.
103. [103] Borak, B., et al. In vivo study on the biodistribution of silica particles in the bodies of rats. Adv. Clin. Exp. Med. 21:1 (2012), 13–18.
104. [104] Sun, J., et al. Cytotoxicity, permeability, and inflammation of metal oxide nanoparticles in human cardiac microvascular endothelial cells. Cell Biol. Toxicol. 27:5 (2011), 333–342.
105. [105] Liu, S.Y., et al. Toxicology studies of a superparamagnetic iron oxide nanoparticle in vivo. Advanced Materials Research, 2008, Trans Tech Publ.
106. [106] Xiong, F., et al. Cardioprotective activity of iron oxide nanoparticles. Sci. Rep., 5, 2015, 8579.
107. [107] Nemmar, A., et al. Ultrasmall superparamagnetic iron oxide nanoparticles acutely promote thrombosis and cardiac oxidative stress and DNA damage in mice. Part. Fibre Toxicol., 13(1), 2016, 22.
108. [108] Baratli, Y., et al. Impact of iron oxide nanoparticles on brain, heart, lung, liver and kidneys mitochondrial respiratory chain complexes activities and coupling. Toxicol. in Vitro 27:2148 (2013), 2142–2148.